Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.575644
Title: The trail pathway in carcinomas : regulation of apoptosis and therapeutic application
Author: Qusty, Naeem Fawzi Hussain
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2013
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
TRAIL is a member of TNF superfamily and binding of TRAIL to its receptors induces cell death with apparent specificity for carcinoma cells compared with normal epithelium. On this basis, a number of TRAIL-targeted therapies are currently under investigation as anti-cancer agents. Recent studies in our lab have shown that membrane bound forms of both FasL and CD40L are more potent in cell death induction, suggesting that a membrane bound TRAIL could be more effective in cell death induction compared to the wild-type or the soluble counterparts. TRAIL gene therapies have demonstrated that ex vivo infection of cancer cells with a recombinant adenovirus expressing TRAIL (RAdTRAIL) enhances apoptosis and promotes tumour regression. In the present study, we have generated two adenoviral vectors. The first one expressing wild-type TRAIL (RAd wtTRAIL) that subject to cleavage from cell membrane and the second adenoviral vector expressing fusion CD40LTRAIL protein that is resistant to metalloproteinase cleavage (RAd CD40LTRAIL). The direct effects of these viruses were examined on TRAIL receptor positive carcinomas either alone or in combination with different chemotherapeutic drug. The RAd CD40LTRAIL that expressed the membrane bound CD40LTRAIL was found to exhibit more cell death than the RAd wtTRAIL. This cell death was through the activation of caspase 3/7.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.575644  DOI: Not available
Keywords: RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Share: